Carcinoma of Unknown Primary
📧 Sign up to get email alerts when something new happens for Carcinoma of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) [Phase 2]
Phase 2 clinical trial results for pembrolizumab in patients with poor-prognosis carcinoma of unknown primary site.
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) [Phase 2]
Phase 2 clinical trial update for pembrolizumab in patients with carcinoma of unknown primary; the study is currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers
This completed trial compares tissue- and liquid-biopsy biomarkers in Carcinoma of Unknown Primary (CUP) to evaluate diagnostic approaches.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS [Phase 3]
Phase 3 clinical trial update examining postoperative pain and hospital stay after transoral robotic surgery for squamous cell carcinoma of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary [Phase 2]
Phase 2 trial of pembrolizumab with concurrent radiation in previously treated carcinoma of unknown primary was terminated, with results pos…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary [Phase 2]
Phase 2 trial update evaluating gemcitabine in patients with metastatic cancer of unknown primary.
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary [Phase 2]
Phase 2 clinical trial update on elective mucosal irradiation for head-and-neck cancer of unknown primary.
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor [Phase 3]
Phase 3 study evaluating radiation therapy for metastases to neck lymph nodes from an unknown primary tumor; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
This entry provides an update on a clinical trial evaluating the use of PET scans and CT scans in patients with locally advanced head and ne…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin [Phase 2]
Phase 2 clinical trial evaluating irinotecan followed by fluorouracil and leucovorin in patients with stage III/IV colorectal cancer, carcin…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary [Phase 2]
Phase 2 trial evaluating gemcitabine and irinotecan in carcinoma of unknown primary has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and everolimus in patients with previously untreated carcinoma of unknown primary. The stu…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated radiation therapy with combination chemotherapy and amifostine for head and neck cancer; the study has completed…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site [Phase 2]
Phase 2 clinical trial update evaluating treatments guided by molecular profiling for carcinoma of unknown primary site; the study has compl…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary [Phase 2]
Phase 2 trial comparing Belinostat, Carboplatin and Paclitaxel (BelCaP) to Carboplatin and Paclitaxel in carcinoma of unknown primary has co…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site [Phase 2]
A Phase 2 trial evaluating first-line therapy with paclitaxel/carboplatin in combination with bevacizumab and erlotinib for carcinoma of unk…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site [Phase 2]
Phase 2 trial evaluating oxaliplatin in combination with capecitabine for relapsed/refractory carcinoma of unknown primary site; the study i…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin [Phase 3]
Phase 3 clinical trial evaluating combination chemotherapy for metastatic carcinoma of unknown primary.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial from Dartmouth-Hitchcock Medical Center evaluated combining chemotherapy with filgrastim in patients with advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer [Phase 3]
Phase 3 trial of radiation therapy combined with chemotherapy for head and neck cancer has completed. The update does not provide efficacy r…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors [Phase 2]
A Phase 2 trial of irinotecan in patients with advanced neuroendocrine tumors, including carcinoma of unknown primary and neuroendocrine car…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site [Phase 3]
Phase 3 randomized trial evaluating gemcitabine/irinotecan/Gefitinib versus paclitaxel/carboplatin/etoposide/Gefitinib in carcinoma of unkno…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy plus peripheral stem cell transplantation in patients with metastatic ca…
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site [Phase 2]
Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with carcinoma of unknown primary; the study status is com…